Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Advancements in NSCLC: from pathophysiological insights to targeted treatments
J Xu, L Tian, W Qi, Q Lv, T Wang - American Journal of Clinical …, 2024 - journals.lww.com
With the global incidence of non-small cell lung cancer (NSCLC) on the rise, the
development of innovative treatment strategies is increasingly vital. This review underscores …
development of innovative treatment strategies is increasingly vital. This review underscores …
[HTML][HTML] The Different Roles of MET in the Development and Treatment of Cancer
J Mollerup, JT Jørgensen - Cancers, 2023 - mdpi.com
This Special Issue features contributions from leading international researchers in the field
of MET (hepatocyte growth factor (HGF) receptor) biology and therapeutics. Recent …
of MET (hepatocyte growth factor (HGF) receptor) biology and therapeutics. Recent …
[PDF][PDF] A Novel Digital PCR Assay for Accurate Detection and Differentiation of Focal and Non-Focal Subtypes of MET Amplification in Lung Cancer
RCM Shek, PSN Li, SCM Leung, HT Chu, F Hioe… - 2025 - preprints.org
Mesenchymal–epithelial transition (MET) gene amplification is a critical biomarker in non-
small cell lung cancer (NSCLC), significantly influencing treatment decisions and prognostic …
small cell lung cancer (NSCLC), significantly influencing treatment decisions and prognostic …
[BOK][B] Roles of MET in Cancer Development and Treatment
JT Jørgensen, J Mollerup - 2023 - researchgate.net
Cover image courtesy of Jens Mollerup© 2023 by the authors. Articles in this book are Open
Access and distributed under the Creative Commons Attribution (CC BY) license. The book …
Access and distributed under the Creative Commons Attribution (CC BY) license. The book …